TB-500

TB-500 is a synthetic peptide modeled after a naturally occurring protein in the body called Thymosin Beta-4. It is used in research due to its potential to support healing, reduce inflammation, and improve blood flow.

TB-500 is classified as a research compound and is not approved for human consumption. This content is intended for educational purposes only.

What is TB-500?

TB-500 is a synthetic peptide that replicates a portion of Thymosin Beta-4 (Tβ4), a naturally occurring protein found in most human tissues and blood platelets. It is involved in tissue regeneration, cell migration, and immune modulation. Research has focused on TB-500's role in accelerating recovery from muscle, tendon, and ligament injuries, as well as improving cardiovascular and skin repair outcomes.

Potential Benefits Shown in Studies

Healing soft tissue like muscles, tendons, and ligaments
Promoting blood vessel growth (angiogenesis)
Supporting healthy circulation
Reducing inflammation and oxidative stress
Improving flexibility and recovery in injured tissue
Supporting cell migration and tissue repair
Enhancing wound healing in skin, eyes, and internal organs

Mechanisms of Action

TB-500's therapeutic potential is largely attributed to:

Upregulating actin-binding proteins to support cell structure and migration
Promoting angiogenesis (the growth of new blood vessels)
Reducing inflammation and oxidative stress at injury sites
Stimulating satellite cell differentiation to repair muscle tissue
Improving circulation and oxygen delivery to damaged tissues

Research Highlights

Actin Regulation & Cellular Repair Activation

TB‑500 influences cytoskeletal dynamics by binding to actin monomers (G-actin), promoting cell mobility and facilitating critical steps in tissue repair.

Source: Lotilabs Research Review

Preclinical Tissue Regeneration & Anti-inflammatory Actions

Animal studies demonstrate that TB‑500 accelerates wound healing, encourages blood vessel formation (angiogenesis), and mitigates inflammation, supporting recovery across multiple tissue types.

Source: Breaking AC Research Overview

Clinical Insights from Thymosin β‑4 Trials

Clinical studies with native thymosin β‑4 (Tβ4) have shown accelerated healing of pressure ulcers and corneal injuries, indicating translational potential for TB‑500 in human tissue repair.

Source: Wikipedia Clinical Overview of Thymosin β‑4